ATE482969T1 - 3-beta-hydroxy-17-(1h-benzimidazol-1-yl)androst - 5,16-dien zur anwendung in der behandlung von prostata-erkrankungen - Google Patents
3-beta-hydroxy-17-(1h-benzimidazol-1-yl)androst - 5,16-dien zur anwendung in der behandlung von prostata-erkrankungenInfo
- Publication number
- ATE482969T1 ATE482969T1 AT06736460T AT06736460T ATE482969T1 AT E482969 T1 ATE482969 T1 AT E482969T1 AT 06736460 T AT06736460 T AT 06736460T AT 06736460 T AT06736460 T AT 06736460T AT E482969 T1 ATE482969 T1 AT E482969T1
- Authority
- AT
- Austria
- Prior art keywords
- diene
- treatment
- methods
- androst
- benzimidazole
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65739005P | 2005-03-02 | 2005-03-02 | |
PCT/US2006/007143 WO2006093993A1 (en) | 2005-03-02 | 2006-03-02 | Novel c-17-heteroaryl steroidal cyp17 inhibitors/antiandrogens: synthesis, in vitro biological activities, pharmacokinetics and antitumor activity |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE482969T1 true ATE482969T1 (de) | 2010-10-15 |
Family
ID=36941503
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06736460T ATE482969T1 (de) | 2005-03-02 | 2006-03-02 | 3-beta-hydroxy-17-(1h-benzimidazol-1-yl)androst - 5,16-dien zur anwendung in der behandlung von prostata-erkrankungen |
Country Status (22)
Country | Link |
---|---|
US (1) | US7875599B2 (de) |
EP (2) | EP2206719B1 (de) |
JP (2) | JP5130453B2 (de) |
KR (1) | KR101380959B1 (de) |
CN (2) | CN103349664A (de) |
AT (1) | ATE482969T1 (de) |
AU (1) | AU2006218711B2 (de) |
BR (1) | BRPI0607523A2 (de) |
CA (1) | CA2599953C (de) |
DE (1) | DE602006017175D1 (de) |
DK (2) | DK2206719T3 (de) |
EA (1) | EA019560B1 (de) |
ES (2) | ES2528055T3 (de) |
HK (1) | HK1115387A1 (de) |
IL (3) | IL185608A (de) |
MX (1) | MX2007010593A (de) |
NZ (1) | NZ561571A (de) |
PL (2) | PL2206719T3 (de) |
PT (2) | PT2206719E (de) |
SI (2) | SI1853619T1 (de) |
WO (1) | WO2006093993A1 (de) |
ZA (1) | ZA200708106B (de) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8569275B2 (en) | 2002-08-28 | 2013-10-29 | Harbor Therapeutics, Inc. | Steroids having 7-oxgen and 17-heteroaryl substitution |
NZ561571A (en) * | 2005-03-02 | 2009-09-25 | Univ Maryland | Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activities, pharmacokinetics and antitumor activity |
GB2454118B (en) | 2007-06-06 | 2010-06-02 | Univ Maryland | Hdac inhibitors and hormone targeted drugs for the treatment of cancer |
WO2009114658A2 (en) * | 2008-03-12 | 2009-09-17 | University Of Maryland, Baltimore | Androgen receptor inactivation contributes to antitumor efficacy of cyp17 inhibitors in prostate cancer |
US20100048912A1 (en) * | 2008-03-14 | 2010-02-25 | Angela Brodie | Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens, In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity |
WO2009120565A2 (en) * | 2008-03-25 | 2009-10-01 | University Of Maryland, Baltimore | Novel prodrugs of c-17-heteroaryl steroidal cyp17 inhibitors/antiandrogens: synthesis, in vitro biological activities, pharmacokinetics and antitumor activity |
US8785423B2 (en) * | 2008-04-14 | 2014-07-22 | University Of Maryland, Baltimore | Compositions and methods of inducing endoplasmic reticulum stress response for the treatment of cell proliferative diseases |
US20110190323A1 (en) | 2008-08-28 | 2011-08-04 | President And Fellows Of Harvard College | Cortistatin analogues and syntheses thereof |
CN102282133A (zh) * | 2008-10-28 | 2011-12-14 | 生物马林药物股份有限公司 | 十氢-1h-茚并喹啉酮和十氢-3h-环戊并菲啶酮cyp17抑制剂 |
US8791095B2 (en) | 2009-02-05 | 2014-07-29 | Tokai Pharmaceuticals, Inc. | Steroidal CYP17 inhibitors/antiandrogens |
GB2514957A (en) * | 2009-02-05 | 2014-12-10 | Tokai Pharmaceuticals Inc | Combination of a 17 alpha-hydroxylase/c17, 20-lyase inhibitor with an additional therapeutic agent |
ES2552087T3 (es) * | 2009-02-05 | 2015-11-25 | Tokai Pharmaceuticals, Inc. | Nuevos profármacos de inhibidores de CYP17 esteroidales/antiandrógenos |
MA33451B1 (fr) | 2009-06-26 | 2012-07-03 | Novartis Ag | Dérivés d'imidazolidin-2-one 1,3-disubstitués en tant qu'inhibiteurs de cyp 17 |
KR20120056267A (ko) * | 2009-08-07 | 2012-06-01 | 토카이 파마슈티컬, 아이엔씨. | 전립선 암의 치료 |
JP5956928B2 (ja) * | 2009-11-13 | 2016-07-27 | トーカイ ファーマシューティカルズ,インク. | 哺乳類のステロイドの代謝物質 |
WO2011066582A1 (en) * | 2009-11-30 | 2011-06-03 | Harbor Biosciences, Inc. | Anticancer compounds and screening method |
EP2627648A1 (de) | 2010-09-16 | 2013-08-21 | Novartis AG | 17a-HYDROXYLASE-C17, 20-LYASE-INHIBITOREN |
RU2013132766A (ru) * | 2010-12-16 | 2015-01-27 | Байомарин Фармасьютикал Инк. | Ингибиторы cyp11b, cyp17 и/или cyp21 |
US9029399B2 (en) | 2011-04-28 | 2015-05-12 | Novartis Ag | 17α-hydroxylase/C17,20-lyase inhibitors |
CN103813794A (zh) * | 2011-07-18 | 2014-05-21 | 拓凯制药公司 | 用于治疗前列腺癌的新型组合物及方法 |
CA2859986A1 (en) * | 2011-12-22 | 2013-06-27 | Tokai Pharmaceuticals, Inc. | Methods and compositions for combination therapy using pi3k/mtor inhibitors |
EP2968370A4 (de) * | 2013-03-14 | 2016-09-21 | Univ Maryland | Mittel zur androgenrezeptor-abwärtsregelung und verwendungen davon |
EP2991644B1 (de) * | 2013-04-04 | 2020-03-25 | University of Maryland, Baltimore | Nichtsteroidale und steroidale verbindungen mit potenter androgenrezeptor-verminderungsregulation und wirkung gegen prostatakrebs |
JP2016528252A (ja) * | 2013-08-12 | 2016-09-15 | トーカイ ファーマシューティカルズ, インコーポレイテッド | アンドロゲン標的治療を使用する新生物障害の処置のためのバイオマーカー |
MY180383A (en) | 2013-12-24 | 2020-11-28 | Harvard College | Cortistatin analogues and syntheses and uses thereof |
CN103694299A (zh) * | 2014-01-13 | 2014-04-02 | 中国药科大学 | 甾体类雄激素受体抑制剂、其制备方法及其医药用途 |
CN105732759A (zh) * | 2015-01-29 | 2016-07-06 | 苏州晶云药物科技有限公司 | (3β)-17-(1H-苯并咪唑-1-基)雄甾-5,16-二烯-3-醇的盐及其制备方法 |
EP3294298A4 (de) | 2015-05-08 | 2018-10-17 | President and Fellows of Harvard College | Cortistatin-analoga, synthese und verwendungen |
EP3316889A4 (de) | 2015-07-01 | 2018-11-14 | President and Fellows of Harvard College | Cortistatin-analoga sowie synthese und verwendungen davon |
WO2017066697A1 (en) | 2015-10-14 | 2017-04-20 | Dou Qingping | Treatments and diagnostics for cancers |
IT201600121375A1 (it) * | 2016-11-30 | 2018-05-30 | Ind Chimica Srl | PROCESSO PER LA PREPARAZIONE DI 3ß-IDROSSI-17-(1H-BENZIMIDAZOL-1-IL)ANDROSTA-5,16-DIENE |
IT201600083406A1 (it) * | 2016-08-08 | 2018-02-08 | Ind Chimica Srl | PROCESSO PER LA PREPARAZIONE DI 3β-IDROSSI-17-(1H-BENZIMIDAZOL-1-IL)ANDROSTA-5,16-DIENE |
ES2700901B2 (es) * | 2016-08-08 | 2019-08-06 | Ind Chimica Srl | Proceso para la preparación de 3ß-hidroxi-17-(1h-benzimidazol-1-il)androsta-5,16-dieno. |
AU2019222652B2 (en) * | 2018-02-13 | 2021-09-02 | Dana-Farber Cancer Institute, Inc. | Cyclin-dependent kinase degraders and methods of use |
WO2019160889A1 (en) * | 2018-02-13 | 2019-08-22 | Dana-Farber Cancer Institute, Inc. | Cyclin-dependent kinase inhibitors and methods of use |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA27440A (en) | 1887-08-16 | James T. Walsh | Art of making sheet metal cans, for packing meats, fruits, vegetables, etc. | |
CH621803A5 (de) * | 1974-08-08 | 1981-02-27 | Siphar Sa | |
US5604213A (en) * | 1992-03-31 | 1997-02-18 | British Technology Group Limited | 17-substituted steroids useful in cancer treatment |
US5994335A (en) | 1997-10-17 | 1999-11-30 | The University Of Maryland, Baltimore | 17-azolyl steroids useful as androgen synthesis inhibitors |
ATE513555T1 (de) | 2003-07-29 | 2011-07-15 | Dompe Spa | Pharmazeutische kombination aus g-csf und plgf für blutstammzellen |
NZ561571A (en) * | 2005-03-02 | 2009-09-25 | Univ Maryland | Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activities, pharmacokinetics and antitumor activity |
-
2006
- 2006-03-02 NZ NZ561571A patent/NZ561571A/en not_active IP Right Cessation
- 2006-03-02 ES ES10150763.0T patent/ES2528055T3/es active Active
- 2006-03-02 ES ES06736460T patent/ES2353413T3/es active Active
- 2006-03-02 SI SI200630861T patent/SI1853619T1/sl unknown
- 2006-03-02 PL PL10150763T patent/PL2206719T3/pl unknown
- 2006-03-02 PL PL06736460T patent/PL1853619T3/pl unknown
- 2006-03-02 JP JP2007558143A patent/JP5130453B2/ja active Active
- 2006-03-02 CN CN2013101036754A patent/CN103349664A/zh active Pending
- 2006-03-02 AT AT06736460T patent/ATE482969T1/de active
- 2006-03-02 EP EP10150763.0A patent/EP2206719B1/de active Active
- 2006-03-02 DK DK10150763.0T patent/DK2206719T3/en active
- 2006-03-02 DK DK06736460.4T patent/DK1853619T3/da active
- 2006-03-02 PT PT101507630T patent/PT2206719E/pt unknown
- 2006-03-02 US US11/817,550 patent/US7875599B2/en active Active
- 2006-03-02 EP EP06736460A patent/EP1853619B1/de active Active
- 2006-03-02 PT PT06736460T patent/PT1853619E/pt unknown
- 2006-03-02 SI SI200631883T patent/SI2206719T1/sl unknown
- 2006-03-02 WO PCT/US2006/007143 patent/WO2006093993A1/en active Application Filing
- 2006-03-02 AU AU2006218711A patent/AU2006218711B2/en active Active
- 2006-03-02 EA EA200701872A patent/EA019560B1/ru not_active IP Right Cessation
- 2006-03-02 BR BRPI0607523-1A patent/BRPI0607523A2/pt not_active IP Right Cessation
- 2006-03-02 MX MX2007010593A patent/MX2007010593A/es active IP Right Grant
- 2006-03-02 KR KR1020077022440A patent/KR101380959B1/ko not_active IP Right Cessation
- 2006-03-02 CA CA2599953A patent/CA2599953C/en active Active
- 2006-03-02 CN CNA2006800064632A patent/CN101155823A/zh active Pending
- 2006-03-02 DE DE602006017175T patent/DE602006017175D1/de active Active
-
2007
- 2007-08-30 IL IL185608A patent/IL185608A/en not_active IP Right Cessation
- 2007-09-20 ZA ZA200708106A patent/ZA200708106B/xx unknown
-
2008
- 2008-05-14 HK HK08105362.1A patent/HK1115387A1/xx not_active IP Right Cessation
-
2011
- 2011-01-06 IL IL210480A patent/IL210480A/en not_active IP Right Cessation
- 2011-01-06 IL IL210478A patent/IL210478A0/en unknown
-
2012
- 2012-09-06 JP JP2012196525A patent/JP5613206B2/ja active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE482969T1 (de) | 3-beta-hydroxy-17-(1h-benzimidazol-1-yl)androst - 5,16-dien zur anwendung in der behandlung von prostata-erkrankungen | |
NO2017019I2 (no) | Enzalutamid eller et farmasøytisk akseptabelt salt derav | |
HK1061354A1 (en) | Synthesis of 4-amino-thalidomide enantiomers | |
EP2044961A3 (de) | Phospholipid-Analoga für die Behandlung von Krebs | |
GEP20084551B (en) | 4-phenylamino-quinazolin-6-yl-amides | |
WO2005013892A3 (en) | Hydrolytically-resistant boron-containing therapeutics and methods of use | |
ZA200703002B (en) | Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity | |
EA200900202A1 (ru) | Селективные модуляторы андрогенного рецептора, их аналоги и производные и их использование | |
ATE450251T1 (de) | Liposomale formulierungen mit dihydrosphingomyelin und verfahren zu ihrer verwendung | |
NO20083002L (no) | Fremgangsmate for anvendelse av CD40-bindende forbindelser | |
IL195256A0 (en) | Compositions of r(+)and s(-)pramipexole and methods of using the same | |
SG152237A1 (en) | Pharmaceutical combinations containing benzoxazine for treating respiratory diseases | |
MXPA06009475A (es) | Derivados de quinazolina y usos terapeuticos de los mismos. | |
UA96277C2 (en) | Benzimidazole derivatives | |
WO2007048097A3 (en) | Anbrosteeone derivatives and method of use thereof | |
MXPA05011699A (es) | Inhibidores de la bomba de protones para el tratamiento de trastornos del abdomen inferior. | |
NO20060655L (no) | 2-alkyliden-19-Nor-vitamin D derivater for behandling av osteofeni eller osteoporose hos hannkjonn | |
PL1732574T3 (pl) | Zastosowanie o-ATP do leczenia chorób związanych z angiogenezą | |
TW200504044A (en) | Methods for preparing derivatives of fungicidal iodochromones and intermediate compounds | |
CY1116024T1 (el) | 3-βητα-υδροξυ-17-(1η-βενζιμιδαζολ-1-υλ)ανδροστα-5,16-διενιο προς χρηση στη θεραπευτικη αγωγη ενος νοσηματος του προστατη |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1853619 Country of ref document: EP |
|
EEFA | Change of the company name |